CO6650346A2 - Composiciones de tetraciclina - Google Patents

Composiciones de tetraciclina

Info

Publication number
CO6650346A2
CO6650346A2 CO12225411A CO12225411A CO6650346A2 CO 6650346 A2 CO6650346 A2 CO 6650346A2 CO 12225411 A CO12225411 A CO 12225411A CO 12225411 A CO12225411 A CO 12225411A CO 6650346 A2 CO6650346 A2 CO 6650346A2
Authority
CO
Colombia
Prior art keywords
tetracycline
compositions
tetracycline compositions
divalent
concerned
Prior art date
Application number
CO12225411A
Other languages
English (en)
Inventor
David Griffith
Serge Boyer
Original Assignee
Rempex Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=44914987&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=CO6650346(A2) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Rempex Pharmaceuticals Inc filed Critical Rempex Pharmaceuticals Inc
Publication of CO6650346A2 publication Critical patent/CO6650346A2/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/65—Tetracyclines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/04—Nitro compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A61K33/26—Iron; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A61K33/34—Copper; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2121/00—Preparations for use in therapy

Abstract

La invención es concerniente con composiciones, composiciones farmacéuticas y métodos para la preparación de las mismas, que comprenden una tetraciclina con estabilidad y solubilidad mejoradas. Algunas modalidades incluyen una tetraciclina con un exceso de un catión divalente o trivalente.
CO12225411A 2010-05-12 2012-12-12 Composiciones de tetraciclina CO6650346A2 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US33410610P 2010-05-12 2010-05-12
US39230410P 2010-10-12 2010-10-12

Publications (1)

Publication Number Publication Date
CO6650346A2 true CO6650346A2 (es) 2013-04-15

Family

ID=44914987

Family Applications (1)

Application Number Title Priority Date Filing Date
CO12225411A CO6650346A2 (es) 2010-05-12 2012-12-12 Composiciones de tetraciclina

Country Status (22)

Country Link
US (5) US9278105B2 (es)
EP (2) EP2568987B1 (es)
JP (2) JP6025712B2 (es)
KR (1) KR101799304B1 (es)
CN (1) CN102970992B (es)
AU (1) AU2011252919B2 (es)
BR (1) BR112012028524B1 (es)
CA (1) CA2799079C (es)
CL (1) CL2012003168A1 (es)
CO (1) CO6650346A2 (es)
DK (1) DK2568987T3 (es)
ES (2) ES2715551T3 (es)
HK (1) HK1180586A1 (es)
HU (1) HUE033161T2 (es)
IL (1) IL222896A (es)
MX (1) MX347919B (es)
PL (1) PL2568987T3 (es)
PT (1) PT2568987T (es)
RU (1) RU2647972C2 (es)
SG (1) SG185513A1 (es)
WO (1) WO2011143503A2 (es)
ZA (1) ZA201208466B (es)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2647972C2 (ru) 2010-05-12 2018-03-21 Ремпекс Фармацеутикалс, Инк. Тетрациклиновая композиция
CN102697739B (zh) * 2012-05-31 2014-10-29 丽珠医药集团股份有限公司 一种减少替加环素差向异构体化的粉针剂制备方法
IN2013MU01127A (es) * 2013-03-26 2015-05-01 Astron Res Ltd
WO2014167575A2 (en) 2013-03-26 2014-10-16 Astron Research Limited Stable tigecycline composition
US20140323443A1 (en) * 2013-04-30 2014-10-30 Fresenius Kabi Usa, Llc Tigecycline formulations
TW201705962A (zh) 2015-03-23 2017-02-16 生物製藥Ｘ公司 皮膚用四環素醫藥組成物
PT108978B (pt) * 2015-11-24 2020-03-09 Hovione Farm S A Sais de tetraciclinas
GB201904851D0 (en) 2019-04-05 2019-05-22 Katholieke Univ Leven Melanoma treatment
WO2021063468A1 (en) * 2019-10-02 2021-04-08 Anfarm Hellas S.A. Stable parenteral pharmaceutical composition containing tigecycline and process for the preparation thereof
CN113101371A (zh) * 2021-04-07 2021-07-13 中国科学院大学温州研究院(温州生物材料与工程研究所) 一种基于阳离子-π作用的疏水药物的增溶方法

Family Cites Families (99)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2736725A (en) 1954-03-11 1956-02-28 American Cyanamid Co Complexes of tetracycline antibiotics and preparation of same
GB812138A (en) 1954-06-17 1959-04-22 American Cyanamid Co Improvements relating to antibiotic composition
GB793558A (en) 1954-07-07 1958-04-16 Pfizer Improvements in or relating to tetracycline preparations
GB809015A (en) 1956-01-16 1959-02-18 Pfizer & Co C Stable aqueous suspensions of tetracycline
DE1228252B (de) 1956-01-16 1966-11-10 Pfizer & Co C Verfahren zur Herstellung eines in waessrigem Medium leicht resuspendierbaren und bestaendigen Mg-Tetracyclinsalzes
GB845454A (en) 1956-06-27 1960-08-24 American Cyanamid Co Preparation of improved tetracycline antibiotic compositions
DE1053734B (de) 1956-06-27 1959-03-26 American Cyanamid Co Verfahren zur Loeslichmachung und Stabilisierung der Tetracyclinantibiotika
US3232834A (en) 1957-06-27 1966-02-01 Pfizer & Co C Antibiotic preparations
US2980584A (en) 1957-10-29 1961-04-18 Pfizer & Co C Parenteral magnesium oxytetracycline acetic or lactic acid carboxamide vehicle preparation
GB879629A (en) 1958-12-05 1961-10-11 American Cyanamid Co Improvements in or relating to stable 6-demethyl-tetracycline antibiotic compositions
GB901107A (en) 1959-06-29 1962-07-11 Pfizer Therapeutic composition and method of preparing same
DE1163318B (de) 1960-04-12 1964-02-20 Pfizer & Co C Verfahren zur Herstellung von Tetracyclin-Verbindungen
GB948090A (en) 1960-04-21 1964-01-29 American Cyanamid Co Improvements in or relating to tetracycline complexes
DE1144721B (de) 1960-04-21 1963-03-07 American Cyanamid Co Verfahren zur Herstellung von Tetracyclin-Komplexverbindungen
FR1430859A (es) 1960-05-23 1966-05-25
US3166474A (en) 1961-05-26 1965-01-19 American Cyanamid Co Stable aqueous propylene glycol solutions of aluminum gluconate complexes of certain tetracycline antibiotics
US3335055A (en) 1961-08-30 1967-08-08 American Cyanamid Co More stable and more soluble tetracycline compositions suitable for parenteral use and method of preparing same
USRE26253E (en) 1963-05-17 1967-08-15 And z-alkylamino-g-deoxytetracycline
US3275513A (en) 1963-05-29 1966-09-27 American Cyanamid Co Stable calcium tetracycline compositions
GB1120821A (en) 1965-03-09 1968-07-24 Rit Rech Ind Therapeut Derivatives of tetracycline antibiotics
ES324597A1 (es) 1966-03-23 1967-02-01 Gallardo Antonio Sa Procedimiento para la obtencion de complejos estables de 4-dimetilamino-1,4,4a,5,5a,6,11,12a-octahidro-3,6,10,12,12a-pentahidroxi-6-metil-1,11-dioxo-2-naftacen carboxamida.
DE1767891C3 (de) 1968-06-28 1980-10-30 Pfizer Verfahren zur Herstellung von wäßrigen arzneilichen Lösungen für die parenterale, perorale und lokale Anwendung mit einem Gehalt an einem Tetracyclinderivat
BE786427A (fr) 1971-07-19 1973-01-18 Pfizer Compositions aqueuses de doxycycline
US4038315A (en) * 1972-05-11 1977-07-26 American Cyanamid Company Isolation and recovery of calcium chloride complex of 7-dimethylamino-6-dimethyl l-6-deoxytetracycline hydrochloride
US3957980A (en) * 1972-10-26 1976-05-18 Pfizer Inc. Doxycycline parenteral compositions
US4060605A (en) 1973-09-28 1977-11-29 Ankerfarm, S.P.A. Water-soluble derivative of 6-deoxy-tetracyclines
US4018889A (en) 1976-01-02 1977-04-19 Pfizer Inc. Oxytetracycline compositions
JPS61130228A (ja) * 1984-11-29 1986-06-18 Sunstar Inc ミノサイクリンを安定に配合した組成物
US4701320A (en) * 1984-11-29 1987-10-20 Lederle (Japan), Ltd. Composition stably containing minocycline for treating periodontal diseases
IE74244B1 (en) 1985-10-01 1997-07-16 Bimeda Res Dev Ltd A process for preparing an antibiotic composition
FR2608044B1 (fr) 1986-12-10 1992-09-11 Sogeval Composition antibiotique aqueuse a usage veterinaire
US4999194A (en) 1988-01-14 1991-03-12 Collaborative Research, Inc. Two-chain urokinase plasminogen activators for treatment of thrombotic disease
IL89894A0 (en) 1988-04-13 1989-12-15 Pfizer Single dose intramuscular treatment of chlamydia trachomatis infections
US5075295A (en) * 1989-12-12 1991-12-24 Boehringer Ingelheim Animal Health, Inc. Novel oxytetracycline compositions
US5494903A (en) 1991-10-04 1996-02-27 American Cyanamid Company 7-substituted-9-substituted amino-6-demethyl-6-deoxytetracyclines
SG52361A1 (en) 1991-10-04 1998-09-28 American Cyanamid Co Novel 7-substituted-9-substituted amino-6-demethyl-6-deoxytetracyclines
GB9413873D0 (en) 1994-07-09 1994-08-31 Norbrook Lab Ltd Long-acting oxytetracycline composition
US6310053B1 (en) * 1995-07-05 2001-10-30 Norbrook Laboratories Limited Long-acting oxytetracycline composition
FR2740686B1 (fr) 1995-11-03 1998-01-16 Sanofi Sa Formulation pharmaceutique lyophilisee stable
CA2253980C (en) 1996-05-23 2004-08-17 Samyang Corporation Locally administrable, biodegradable and sustained-release pharmaceutical composition for periodontitis and process for preparation thereof
US6245735B1 (en) 1996-07-29 2001-06-12 The Brigham And Women's Hospital, Inc. Methods and products for treating pseudomonas infection
KR100252699B1 (ko) * 1998-03-17 2000-12-01 강재헌 치주염 치료용 미노사이클린 조성물
JPH11286448A (ja) 1998-04-01 1999-10-19 Showa Yakuhin Kako Kk ミノサイクリン含有組成物
IN183807B (es) 1998-04-22 2000-04-22 Hindustan Antibiotics Ltd
US6432934B1 (en) 1998-08-06 2002-08-13 Advanced Vision Research Methods and compositions for topical treatment of eye surface inflammation and related dry eye disease
BR9804395A (pt) 1998-11-04 2000-06-06 Hoechst Roussel Vet S A Brasil Composição farmacêutica injejetável, de longa ação, à base de uma tetraciclina.
US20040131628A1 (en) 2000-03-08 2004-07-08 Bratzler Robert L. Nucleic acids for the treatment of disorders associated with microorganisms
WO2001092288A2 (en) 2000-05-31 2001-12-06 Mayo Foundation For Medical Education And Research Cobalamin compounds useful as antibiotic agents and as imaging agents
US20100010101A1 (en) 2000-07-05 2010-01-14 Capricorn Pharma, Inc. Rapid-Melt Compositions and Methods of Making Same
AU2001279284A1 (en) 2000-07-05 2002-01-14 Capricorn Pharma, Inc Rapid-melt semi-solid compositions, methods of making same and methods of using same
US6375982B1 (en) 2000-07-05 2002-04-23 Capricorn Pharma, Inc. Rapid-melt semi-solid compositions, methods of making same and method of using same
AU2001287198A1 (en) 2000-08-22 2002-03-04 Jeneric/Pentron, Incorporated Dental restorative compositions and method of use thereof
IL145751A (en) 2001-10-04 2010-12-30 Avi Dascalu Use of aluminum fluoride for the preparation of compositions for the treatment of acne vulgaris and folliculitis
EP1438019A1 (en) 2001-10-24 2004-07-21 PARI GmbH Spezialisten für effektive Inhalation Kit for the preparation of a pharmaceutical composition
US20040235801A1 (en) 2001-10-25 2004-11-25 Jean-Pierre Julien Therapy for stroke
US20030083318A1 (en) 2001-10-25 2003-05-01 Jean-Pierre Julien Therapy for neurodegenerative diseases
US20030171340A1 (en) 2002-02-07 2003-09-11 Jenefir Isbister Methods of disease treatment using metal-complexed tetracycline antibiotics
EP1503981A4 (en) * 2002-03-21 2007-08-15 Paratek Pharm Innc SUBSTITUTED TETRACYCLINE COMPOUNDS
WO2004000223A2 (en) * 2002-06-20 2003-12-31 Orapharma, Inc. Rapidly disintegrating formulations for treating or preventing mucositis
IL166156A0 (en) 2002-07-09 2006-01-15 Point Therapeutics Inc Boroproline compound combination therapy
CN1390550A (zh) * 2002-07-25 2003-01-15 于航 盐酸米诺环素冻干粉针剂及其制备方法
RU2273232C2 (ru) 2003-07-21 2006-04-10 Олег Иванович Квасенков Способ получения желейного мармелада
EP1653932A1 (en) 2003-07-24 2006-05-10 Ranbaxy Laboratories Limited Modified release compositions for minocycline
CN1893956A (zh) * 2003-07-25 2007-01-10 沃纳奇尔科特公司 多西环素金属络合物固体剂型
CN1562045A (zh) 2004-04-02 2005-01-12 北京正大绿洲医药科技有限公司 强力霉素滴丸
BRPI0512923A (pt) 2004-06-30 2008-04-15 Omega Bio Pharma I P 1 Ltd materiais e métodos para melhorar a saúde, imunidade e crescimento de mariscos
US20060141054A1 (en) 2004-10-25 2006-06-29 Thomas Piccariello Metal coordinated compositions
US7799937B2 (en) 2004-10-25 2010-09-21 Synthonics, Inc. Metal coordinated compositions
AU2006206359B2 (en) * 2005-01-21 2011-03-31 Allergan Pharmaceuticals International Limited A tetracycline metal complex in a solid dosage form
CN102512429A (zh) * 2005-03-14 2012-06-27 惠氏公司 替加环素组合物及制备方法
AR057033A1 (es) 2005-05-27 2007-11-14 Wyeth Corp Tigeciclina y metodos para preparar 9-nitrominociclina
AU2006331688A1 (en) 2005-12-22 2007-07-05 Wyeth Oral formulations comprising tigecycline
RU2008121238A (ru) * 2005-12-22 2010-01-27 Вайет (Us) Способы лечения инфекций желудочно-кишечного тракта с применением тайгециклина
ES2609976T3 (es) 2006-01-27 2017-04-25 Yale University Combinación de sal de cinc y agente anti-H. pylori como inhibidor de acción rápida de la secreción de ácido gástrico
ES2315123B1 (es) 2006-09-25 2009-12-30 Divasa-Farmavic, S.A. Composiciones farmaceuticas estables de tetraciclinas en solucion, procedimiento para su obtencion y sus usos.
US20080188445A1 (en) 2007-02-02 2008-08-07 Warner Chilcott Company Inc. Tetracycline compositions for topical administration
CN101254156B (zh) 2007-03-01 2011-05-25 段亚东 一种化妆品组合物及其制备化妆品的用途
CN101678108A (zh) * 2007-03-23 2010-03-24 分子研究中心公司 包含四环素类的抗炎组合物及其用途
WO2008121107A1 (en) 2007-04-02 2008-10-09 Medicis Pharmaceutical Corporation Minocycline oral dosage forms for the treatment of acne
US20080248124A1 (en) 2007-04-03 2008-10-09 Sunstar Kabushiki Kaisha Process for producing pharmaceutical composition
US8828363B2 (en) 2007-08-03 2014-09-09 Gary H. EIREW Pharmaceutical composition for improving oral hygiene and methods thereof
AU2008299220B2 (en) 2007-09-10 2011-07-21 Calcimedica, Inc. Compounds that modulate intracellular calcium
US20090111780A1 (en) 2007-10-31 2009-04-30 Everett Laboratories, Inc. Compositions and methods for treatment of ear canal infection and inflammation
US8389567B2 (en) 2007-12-12 2013-03-05 Calcimedica, Inc. Compounds that modulate intracellular calcium
JP2011512351A (ja) 2008-02-15 2011-04-21 プレジデント・アンド・フェロウズ・オブ・ハーバード・カレッジ 心臓手術のための心停止液
PT2271348T (pt) 2008-03-28 2018-04-16 Paratek Pharm Innc Formulação de comprimido oral de composto de tetraciclina
US9107929B2 (en) 2008-05-01 2015-08-18 Ranbaxy Laboratories Limited Stable parenteral formulations of tigecycline
CN101301268A (zh) 2008-06-11 2008-11-12 成都乾坤动物药业有限公司 一种兽用盐酸多西环素注射液的组成及其制备工艺
EP2306972A1 (en) * 2008-06-23 2011-04-13 Danmarks Tekniske Universitet Acetic acid and a buffer
MX2011001812A (es) 2008-08-18 2011-07-29 Nanotherapeutics Inc Composicion topica de hidrogel.
WO2010033800A2 (en) * 2008-09-19 2010-03-25 Alacrity Biosciences, Inc. Tetracycline stabilizing formulations
US20110257177A1 (en) 2008-09-22 2011-10-20 Calcimedica, Inc. Benzylthiotetrazole inhibitors of store operated calcium release
WO2010034011A2 (en) 2008-09-22 2010-03-25 Calcimedica, Inc. Phenylthiophenyldihydrobenzothiazepine inhibitors of store operated calcium release
WO2010046932A2 (en) 2008-10-21 2010-04-29 Jubilant Organosys Limited Extended release pharmaceutical composition of minocycline and process thereof
BRPI1007885A2 (pt) 2009-02-03 2016-02-16 Microbion Corp bismuto-tóis antissépticos para tecidos epiteliais, feridas agudas e crônicas, biofilmes bacterianos e outras indicações
CN101607086B (zh) 2009-07-21 2011-11-02 山西安特生物制药股份有限公司 一种复方铋剂组合物及其制备方法
CN101822650B (zh) 2010-04-28 2012-06-20 中国科学院上海生命科学研究院湖州营养与健康产业创新中心 一种盐酸米诺环素缓释片及其制备方法
RU2647972C2 (ru) 2010-05-12 2018-03-21 Ремпекс Фармацеутикалс, Инк. Тетрациклиновая композиция
CN101940560A (zh) 2010-09-16 2011-01-12 孙卫东 一种盐酸米诺环素缓释片及其不同规格的制备方法

Also Published As

Publication number Publication date
WO2011143503A3 (en) 2012-01-19
WO2011143503A2 (en) 2011-11-17
DK2568987T3 (en) 2017-02-20
PT2568987T (pt) 2017-02-03
CA2799079A1 (en) 2011-11-17
KR20130080797A (ko) 2013-07-15
CA2799079C (en) 2019-01-15
CN102970992B (zh) 2016-07-06
US9278105B2 (en) 2016-03-08
US9744179B2 (en) 2017-08-29
ES2613738T3 (es) 2017-05-25
JP6290298B2 (ja) 2018-03-07
RU2647972C2 (ru) 2018-03-21
BR112012028524B1 (pt) 2022-03-15
CL2012003168A1 (es) 2013-12-20
MX2012012993A (es) 2013-08-27
SG185513A1 (en) 2012-12-28
AU2011252919B2 (en) 2017-01-19
EP2568987B1 (en) 2016-11-16
US9084802B2 (en) 2015-07-21
AU2011252919A1 (en) 2012-12-06
EP2568987A2 (en) 2013-03-20
IL222896A (en) 2017-03-30
AU2011252919A2 (en) 2012-12-06
JP6025712B2 (ja) 2016-11-16
EP2568987A4 (en) 2014-05-21
JP2016145253A (ja) 2016-08-12
US20140194393A1 (en) 2014-07-10
RU2012147527A (ru) 2014-06-20
PL2568987T3 (pl) 2017-06-30
US11944634B2 (en) 2024-04-02
MX347919B (es) 2017-05-17
HK1180586A1 (zh) 2013-10-25
EP3135289B1 (en) 2018-12-12
BR112012028524A2 (pt) 2016-07-19
IL222896A0 (en) 2012-12-31
US20180078570A1 (en) 2018-03-22
ES2715551T3 (es) 2019-06-04
US20150094282A1 (en) 2015-04-02
JP2013529201A (ja) 2013-07-18
ZA201208466B (en) 2018-12-19
US20130040918A1 (en) 2013-02-14
CN102970992A (zh) 2013-03-13
KR101799304B1 (ko) 2017-11-20
HUE033161T2 (en) 2017-11-28
EP3135289A1 (en) 2017-03-01
US20200000828A1 (en) 2020-01-02

Similar Documents

Publication Publication Date Title
CO6650346A2 (es) Composiciones de tetraciclina
CL2018002703A1 (es) Agentes de iarn, composiciones y métodos de uso de los mismos para tratar enfermedades asociadas con transtiretina (ttr). (divisional solicitud 201401291)
CY1120529T1 (el) Προφαρμακα φουμαρικων αλατων και η χρηση τους στην αγωγη ποικιλων νοσων
CR20140501A (es) Nuevos diazaespirocicloalcanos y azaespirocicloalcanos
BR112013003388A2 (pt) sal de besilato de um inibidor de btk
BR112013029785A2 (pt) dispositivo de varredura para interferometria de coerência baixa
CR20140229A (es) Nuevos derivados bicíclicos de dihidroisoquinolin-1-ona
BR112013028281A2 (pt) compostos e composições para inibição de nampt
UY34763A (es) Inhibidores de la agregación plaquetaria
CR20140468A (es) Inhibidores de diacilglicerol aciltransferasa 2
CY1123056T1 (el) Νεα μορφη χορηγησης της ρασεκαδοτριλης
BR112015030203A2 (pt) moléculas pequenas inibidores da fibrose
ECSP11011391A (es) Métodos y productos intermedios para preparar agentes farmacéuticos
BR112012031906A2 (pt) métodos e composições para modular o crescimento de cabelo e pelos.
CR20130539A (es) Triazolopiridinas
UY34467A (es) Procedimiento para la preparación de 5-fluoro-1h-pirazolopiridinas sustituidas
EA201690764A1 (ru) Ингибитор грелин-o-ацилтрансферазы
UY33906A (es) Composiciones herbicidas que comprenden topramezona
BR112015025852A2 (pt) as formulações de oxabicicloheptanos e oxabicicloheptenos
GT201500247A (es) Imidazopiridazinas sustituidas
BR112013025866A2 (pt) formulações com viscosidade reduzida
DOP2018000066A (es) Compuestos útiles para inhibir ror-gamma-t
UY34166A (es) Composición farmacéutica oftalmológica tópica que contiene regorafenib
EA201270728A1 (ru) Пуриновые соединения
PE20150167A1 (es) (r)-nifuratel, su uso para el tratamiento de las infecciones y sintesis de (r) y (s)-nifuratel